This study assessed the gene MAP1A expression in bladder cancer and correlated to the survival bioinformatically from TCGA and GEO databases and verified by differential gene expression and survival analysis using the GEPIA database. The gene discussed is MAP1A; the disease is urinary bladder cancer.